Nyang'wa B.T, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Solodovnikova V, Liverko I, Moodliar R, Dodd M, Ngubane N, Rassool M, McHugh T.D, Spigelman M, Moore D.A.J, Ritmeijer K, du Cros P, Fielding K, TB-PRACTECAL Study Collaborators. A 24-week, all-oral regimen for rifampin-resistant tuberculosis. N Engl J Med. 2022;387(25):2331-2343. DOI: 10.1056/NEJMoa2117166

2022
Journal Article
PubMed